- OVERALL This application is for continued support of the Vanderbilt Digestive Disease Research Center (VDDRC). Our long-term objective is to develop a deeper understanding of gastrointestinal pathophysiology in order to reveal new disease mechanisms and identify novel therapeutic targets. Our vision is to continue to inspire interest in the study of digestive diseases and perform paradigm-shifting science that translates to benefit for the patients and communities we serve. The VDDRC is multidisciplinary, including faculty in 14 different academic departments with 84 investigators (54 full members and 30 associate members).
The Aims of the VDDRC are to: 1) promote digestive diseases research in an integrative, collaborative, and multidisciplinary manner; 2) attract new investigators to the study of these disorders; 3) enhance the innovative research capabilities of members; and 4) promote the career development of junior investigators. The overarching VDDRC theme is the study of microbial and host constituents that impact digestive disease pathobiology within the context of inflammation and the environment and investigative member interests fall into three interactive areas of study: 1) Gastrointestinal Infections and Injury; 2) Progenitor Cells, Development, Regeneration, and Pre-malignant Lesions; and 3) Obesity, Metabolism, and Nutrition. The VDDRC contains four core research laboratories to support members: 1) Flow Cytometry Core, 2) Preclinical Models of Digestive Diseases Core, 3) Cell Imaging Core, and 4) Mass Spectrometry/Proteomics Core. These cores are well engrafted into our Center to provide investigators working on digestive disease-related research with the latest advances in technology, to actively promote collaborations, and to aid in experimental design and interpretation of results. Based directly on investigator demand, we have now expanded our core services by adding organoid development to the Preclinical Models of Digestive Diseases Core, and created the VDDRC Academy of Investigators as a Component of the Enrichment Program to provide career development and support to junior investigators. The VDDRC supports a Pilot/Feasibility Program including a university-supported translational project, a dual- funded VDDRC-Clinical and Translational Science Award clinical project, and a Young Investigator Award Program to foster participation of beginning and seasoned investigators in research related to digestive diseases. The Administrative Core also contains Biostatistical and Enrichment Programs and oversees the financial management and operation of the VDDRC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK058404-19
Application #
9980871
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Perrin, Peter J
Project Start
2002-06-01
Project End
2022-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Lindsey, Amelia R I; Rice, Danny W; Bordenstein, Sarah R et al. (2018) Evolutionary Genetics of Cytoplasmic Incompatibility Genes cifA and cifB in Prophage WO of Wolbachia. Genome Biol Evol 10:434-451
Lopez, Christopher A; Skaar, Eric P (2018) The Impact of Dietary Transition Metals on Host-Bacterial Interactions. Cell Host Microbe 23:737-748
Roberts, Jordan; Gonzalez, Raul S; Revetta, Frank et al. (2018) Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells. Histopathology 73:795-800
Schulte, Michael L; Fu, Allie; Zhao, Ping et al. (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194-202
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255
Mera, Robertino M; Bravo, Luis E; Camargo, M Constanza et al. (2018) Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut 67:1239-1246
Skoog, Emma C; Morikis, Vasilios A; Martin, Miriam E et al. (2018) CagY-Dependent Regulation of Type IV Secretion in Helicobacter pylori Is Associated with Alterations in Integrin Binding. MBio 9:
Gibson, William E; Gonzalez, Raul S; Cates, Justin M M et al. (2018) Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. Hum Pathol 79:109-115
Galligan, James J; Wepy, James A; Streeter, Matthew D et al. (2018) Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks. Proc Natl Acad Sci U S A 115:9228-9233

Showing the most recent 10 out of 1365 publications